glutathione and triple negative breast cancer Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven metalloimmunotherapy for triple- Metabolic interplay between exogenous cystine
Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Ratiometrically designed nanoprodrug for triple negative breast cancer treatment Involvement of glutathione peroxidases in the occurrence and development of breast cancers Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9





